First AD

Second AD

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Advances in Treatment and Management of Immune Thrombocytopenia 

Peer Exchange

Shared insight on treatment goals for immune thrombocytopenia and how physicians might optimally select frontline therapy.

Optimizing Frontline Therapy in ITP: Treatment Selection and Goals

Making a Diagnosis of Immune Thrombocytopenia

Observation vs Initiating Frontline Therapy in Patients With ITP

Defining Chronic or Persistent Immune Thrombocytopenia 

What is the Role of Splenectomy in Chronic Immune Thrombocytopenia? 

Use of Rituximab Therapy in Chronic Immune Thrombocytopenia

Chronic Immune Thrombocytopenia: Considerations for Fostamatinib Therapy

Thrombopoietin Receptor Agonists in Pediatric Immune Thrombocytopenia

Selecting an Oral TPO-RA for Chronic Immune Thrombocytopenia

Selecting an Injectable TPO-RA for Chronic Immune Thrombocytopenia